Bioventus Inc (BVS)
13.71
+0.13
(+0.96%)
USD |
NASDAQ |
Nov 04, 16:00
12.32
-1.39
(-10.14%)
Pre-Market: 08:53
Bioventus Free Cash Flow: 8.443M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | 8.443M |
| March 31, 2024 | 2.756M |
| December 31, 2023 | 7.982M |
| September 30, 2023 | -1.66M |
| June 30, 2023 | 7.819M |
| March 31, 2023 | -0.67M |
| December 31, 2022 | -25.06M |
| September 30, 2022 | -28.62M |
| June 30, 2022 | -18.23M |
| Date | Value |
|---|---|
| March 31, 2022 | -3.944M |
| December 31, 2021 | 2.101M |
| September 30, 2021 | 12.41M |
| June 30, 2021 | 22.45M |
| March 31, 2021 | 14.32M |
| December 31, 2020 | 51.13M |
| September 30, 2020 | 39.54M |
| June 30, 2020 | 15.86M |
Free Cash Flow Range, Past 5 Years
-28.62M
Minimum
Sep 2022
51.13M
Maximum
Dec 2020
6.272M
Average
7.819M
Median
Jun 2023
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Insulet Corp | 182.40M |
| Perspective Therapeutics Inc | -24.58M |
| Xtant Medical Holdings Inc | -17.52M |
| Catheter Precision Inc | -7.444M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 15.16M |
| Cash from Investing (Quarterly) | -0.077M |
| Cash from Financing (Quarterly) | -7.845M |
| Free Cash Flow Per Share (Quarterly) | 0.2355 |
| Free Cash Flow to Equity (Quarterly) | 23.04M |
| Free Cash Flow to Firm (Quarterly) | 23.16M |
| Free Cash Flow Yield | 0.97% |